PSP Research »

Oruka Therapeutics shares owned by PSP Research

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $244k 5.0k 49.05

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Vanguard Group
Deep Track Capital
Rtw Investments
Commodore Capital
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
venBio Select Advisor
Blackstone Group
Polar Capital Holdings

View all funds holding Oruka Therapeutics